Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From the Aug 17th earnings call

<What is our current interest in Talis? Preferred shares?>

38.9% of the membership units, whatever they are.

Opty

Share
New Message
Please login to post a reply